Jeremy VisserJul 14, 20231 minSafety of Deucravacitinib in Asian PatientsDr. Ron Vender reviews the safety of deucravacitinib in Asian patients at WCD2023 in Singapore.
Jeremy VisserJul 14, 20231 minPASI Reductions for an Oral TYK2 InhibitorDr. Ron Vender reviews a poster about deucravacitinib.
Jeremy VisserJul 13, 20231 minLong Term Efficacy of DeucravacitinibDr. Ron Vender reviews the TYK2 inhibitor deucravacitinib at WCD2023 in Singapore.
Jeremy VisserJul 13, 20231 minOral and Topical JAK InhibitorsDr. Ron Vender discusses JAK and TYK2 inhibitors at WCD2023 in Singapore.
Jeremy VisserJul 12, 20231 minVIDEO: Study shows lower fertility rates in patients with moderate-to-severe plaque psoriasisPatients with moderate-to-severe plaque psoriasis have lower fertility rates and higher risk of pregnancy loss than women with psoriasis.
Jeremy VisserJul 12, 20231 minPhase II Trial for an Oral Peptide to Treat Plaque PsoriasisDr. Ron Vender discusses the late breaking study of an oral peptide to treat moderate-to-severe psoriasis at WCD2023 in Singapore.